Most medical technology entrepreneurs will tell you that in recent years, reimbursement has become as large of a barrier to successful commercialization as regulatory clearance. Medical device manufacturers that do not plan early for reimbursement risk prolonged delays in bringing products to the market as the FDA approval/clearance process is an extremely important, single, sentinel event.
In order to maximize resource efficiency and speed-to-market, medical organizations should begin reimbursement planning early and allow full integration into the associated regulatory and clinical planning.
Join us for this NAMSA webinar, presented by Edward Black, Director of Global Reimbursement Strategy, as we present information on:
- Understanding the basic principles of reimbursement strategy
- Determining how reimbursement strategy can be incorporated into the broader business plan to achieve success
- Proactively addressing reimbursement barriers prior to FDA clearance (coding, coverage and payment) to achieve time and cost efficiencies